The HUPHAR annual congress will be held in Mátraháza between June 3–5, 2026, with the participation of international pharmacologists. We kindly ask our members to mark the date. Further details will be provided continuously and will also be published on the conference website: https://huphar.org/huphar2026
Videos recorded at last year’s conference – including plenary and keynote lectures – are available on our YouTube channel: https://www.youtube.com/@HUPHAR
We would like to draw the attention of our early-career members to the YoungPharm – Satellite Meeting, which will take place on June 2, 2026, at the Hungarian Academy of Sciences’ Mátraháza Guesthouse. This newly launched event, consisting of two half-day sessions, is designed for young researchers and offers a unique, supportive forum to present their work, increase visibility, and participate in interactive scientific discussions.
There is no additional registration fee for participation in the YoungPharm program. Registration is available at: https://events.altagra.hu/huphar2026
For general information, registration details, and the preliminary program, please visit: https://huphar.org/huphar2026/youngpharm-satellite-meeting-for-the-next-generation-by-huphar-2
The upcoming Executive Board Meeting will be held on Wednesday, April 15, 2026, starting at 11:00, followed by the General Assembly at 13:00. Detailed invitations, including the agenda items, will be sent shortly. We kindly ask our members to reserve the date and times in their calendars.
The IUPHAR satellite symposium, the 14th International Symposium on Cell/Tissue Injury & Cytoprotection/Organoprotection (ISCTICO-2026), will be held in Zagreb between July 8–10, 2026, focusing on cellular, tissue, and organ protection. HUPHAR members are warmly invited by the organizers.
There is no registration fee. Applications can be submitted via: https://isctico-zagreb2026.com/
The latest achievements and technological developments in pharmaceutical research were highlighted at the conference entitled “The Future of Drug Research: Science and Innovation”, organized by the Gábor Dénes Awardees’ Club Association on November 13, 2025, at the HUN-REN Research Centre for Natural Sciences.
Our society was represented by Prof. Zsuzsanna Helyes, President of HUPHAR, in the panel discussion “Venture Capital and Start-Ups in Drug Development.”
Dr. Renáta Papp delivered a lecture entitled “Environmental Impacts of the Pharmaceutical Industry and the Ecological Responsibility of Clinical Decision-Making.”
We welcome suggestions from our members regarding future elements of this event series.
Local Medical and Health Sciences Student Research (TDK) Conferences were held at Hungarian medical and pharmacy universities. The Special Awards of the Hungarian Society for Experimental and Clinical Pharmacology were granted to the following students:
University of Pécs
Attila Cserményi (III)
Institute of Organic and Medicinal Chemistry
Effect of molecular environment on the effectiveness of photoswitches applied in pharmacology
Rebeka Petrák (VI)
Institute of Pharmacology and Pharmacotherapy
Alleviation of chronic stress-induced pain by inhibition of neuroinflammatory signaling
Lajos Karakai (IV)
Institute of Pharmacology and Pharmacotherapy
Antitumor effect via disruption of lipid rafts
University of Szeged
Sára Pető, Faculty of Science and Informatics (BSc, Year III)
TRPV4 inhibition reduces spreading depolarization and astrocyte activation in mouse brain slices
Dóra Szabó, Faculty of Medicine (Year V)
Trastuzumab reduces the expression of syndecan-4 proteoglycan and G1/S cell cycle regulators in human rhabdomyosarcoma
Mihály Erős, Faculty of Science and Informatics (MSc, Year I)
Neuroprotective effects of trifluoperazine in an acute ischemic stroke mouse model
University of Debrecen
Evgeniya Mezhonova
Institute of Pharmacology
BGP-15 Modulates Cardiac Function Independent of Autonomic Signalling
Semmelweis University
Alma Lolita Hullám, Faculty of Pharmacy (Year V)
Institute of Pharmacology and Pharmacotherapy
Effects of TAAR1 agonist compounds (Selegiline, BPAP) in various behavioral pharmacology tests
Wen-Wei Hung, Faculty of Medicine (Year V)
Institute of Pharmacology and Pharmacotherapy
MSC-Derived Small EVs Protect Against Doxorubicin and Distinct Chemotherapy-Induced Cardiotoxicity With Donor-Dependent Variation
We would like to inform our early-career members about the EPHAR Early Career Research (ECR) Group initiative. The aim of the group is to connect and mobilize young researchers at the international level, establish direct communication channels, offer targeted program opportunities, and build a structured and sustainable youth network within EPHAR.
To achieve this, they seek to involve early-career members from European communities, enabling direct outreach with relevant programs, initiatives, and opportunities, while fostering continuous interaction, collaboration, and knowledge exchange.
Those interested may apply via: https://docs.google.com/forms/d/e/1FAIpQLSex-POJG3bI9t7NPz2BWnWt3yYjpOLAldoZP1u1eHE4aVjZNQ/viewform?usp=publish-editor
HUPHAR once again counts on the support of all its members and sponsors by donating 1% of their personal income tax. To support HUPHAR through your tax donation, simply complete the 1+1% declaration form via the Client Portal by May 20, 2026, and submit it together with your tax return.
Please enter the following tax identification number in the “Tax number of the civil beneficiary” field:
19000345-2-42
We kindly ask you to also inform your colleagues about this opportunity to support HUPHAR.
We encourage our members to promote the society within their professional networks and invite colleagues to join. New members can register on our website: https://huphar.org/hu
Our Facebook and Instagram pages have been launched, where you can find the latest news and events. To stay updated, follow our pages:
https://www.facebook.com/profile.php?id=61581409634925
https://www.instagram.com/p/DQ4L9UyCGwu/
ZOLGENSMA
